Read + Share
Amedeo Smart
Independent Medical Education
de Haan R, van Werkhoven E, van den Heuvel MM, Peulen HMU, et al. Study protocols of three parallel phase 1 trials combining radical radiotherapy with the PARP inhibitor olaparib. BMC Cancer 2019;19:901.PMID: 31500595
Email
LinkedIn
Facebook
Twitter
Privacy Policy